📌 Key Takeaways
- Topic: Microsilica for Cement: Benefits, Dosage Guidelines and Applications
- Keywords: silicon dioxide covalent network
- Published: 2026-11-20 01:53:26
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica for UV Adhesive: Rheology Control and Transparency Considerations
- What Is Fused Quartz? Properties, Manufacturing Process and Applications
- Hunter, H. M. & Wright, P. A. Synthesis and characterisation of the mesoporous silicate SBA-2 and its performance as an acid catalyst. Micropor. Mesopor. Mater. 43, 361-373 (2001). Piece CAS Google Scholar
- What Is Silica Sol? Composition, Acidic vs Alkaline Types and Industrial Applications
- Silica Particle Size Guide: How D50, Mesh and Microns Affect Performance
- Janjua, T. I., Cao, Y., Yu, C. & Popat, A. Clinical translation of silica nanoparticles. Nat. Rev. Mater. 6, 1072-1074 (2021). Piece CAS PubMed Central PubMed Google Scholar
- Tosoh Silica: Product Range, Applications and Key Grades
What Is Pyrogenic Silica? How It Is Made and Why It Is Used as a Thickener
What is silica (SiO₂)?
silicon dioxide structure
What is the difference between fumed silica and precipitated silica?
colloidal silica Considering these components, substantial efforts have been conducted to go for particular surface functionalization modifications of MSNs to decrease their toxicity such as neurotoxicity, immunotoxicity, and systemic toxicity (Fig. 6a ). A common approach is to integrate the biocompatible polymers with MSNs. Polymers including polyethylene glycol (PEG), polyethylenimine (PEI) and chitosan have been demonstrated to be excellent surface coating agents for MSNs, which can substantially enhance the in vivo circulation time, decrease cytotoxicity and hemolytic effect of MSNs. 295, 296, 297, 298 In terms of decreasing protein adsorption and boosting the colloidal stability of the particles, PEG is at present considered as an extremely excellent polymer. 298, 299, 300 Hao et al. systematically investigated the hemolytic activity and protein adsorption behavior of bare MSNs, MSNs modified with chitosan (MSNs-CS) and MSNs co-modified with chitosan and PEG (MSNs-CS-PEG). 301 Results showed that the hemolysis percentage and protein adsorption of MSNs-CS-PEG were 2% and 3.2%, respectively, which were remarkably lower than those of bare MSNs (30.9% and 14.5%, respectively), and they also exhibited lower toxicity toward MCF-7 cells. 301 This was similarly demonstrated in a study by He et al. 302 As well as polymers, liposomes have the advantages of high biocompatibility, low immunogenicity and long circulation, thereby they can also be used to enhance the biosafety of MSNs. 303, 304, 305 MSNs can be encapsulated by lipid bilayers or multilayers, and these liposomes act as protective shells to reduce toxicity by masking the reactive groups on the surface of MSNs. Compared to bare MSNs, liposome-encapsulated MSNs exhibit superior particle dispersion and lower non-specific binding. 306, 307 Additionally, they lead to the higher bioavailability and the in vivo half-life can be prolonged more than 10-fold, reducing the distribution of MSNs in reticuloendothelial system (RES)-related organs. 306 Protein coating is also a way to boost the biocompatibility and particle stability of MSNs. 308, 309 Negatively charged bull serum albumin (BSA), which is highly physiologically stable during blood circulation, can tightly bind to the amino groups on the MSNs surface, preventing the premature release of drug loaded on the MSNs. 309 Apart from, given that the positively charged MSNs show significant toxicity influence, some researchers have devoted to regulating the surface properties of MSNs by direct group modification. The surface potential of MSNs can be regulated by diverse functionalization via carboxyl (-COOH), phenyl (-Ph), and methyl phosphonate (-PO 3 - ) groups with negative and neutral zeta potentials. 310, 311
What drives silica raw material prices?
SiO2 Hu, X. et al. Biodegradation-mediated enzymatic activity-tunable molybdenum oxide nanourchins for tumor-specific cascade catalytic therapy. J. Am. Chem. Soc. 142, 1636-1644 (2019). Article Google Scholar
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.